Skip to main content

The Barcelona City Council awards Ernest Giralt with the "Ciutat de Barcelona" prize



Emeritus Professor
Tel.+34 93 40 37125


Press & Communications Section Head
Tel.+34 93 40 37255

The Council recognizes the impact of his research in peptide chemistry with applications in innovative therapies for cancer

The "Ciutat de Barcelona" prize represents the highest recognition that gives the city to its citizens

Ernest Giralt, Group Leader of the Peptides and Proteins Laboratory at IRB Barcelona, for which he also serves as programme coordinator of Chemistry and Molecular Pharmacology, has received  the "Ciutat de Barcelona" (City of Barcelona) Award in the category of Experimental Sciences and Technology, the City Council announced this morning.

The council recognizes Dr. Giralt for his "development of a chemical technology that enables a cytotoxic peptide extracted from wasp venom to act selectively in tumor cells without affecting healthy cells, with applications into chemotherapy," according to today's announcement  by the Culture Institute of the City Council. The  study was published in June 2014 in the Journal of Control Release and first author was postdoctoral researcher Miguel Moreno "Delivering wasp venom for cancer therapy"

The awards ceremony will take place on Tuesday, February 10 in the City Council, and will be chaired by Mayor Xavier Trias.

The "Ciutat de Barcelona" awards represent the highest recognition that  he city gives to its citizens. With over sixty years of history, the prizes aim to reward excellence in different fields of creativity, research and culture in the city throughout the year. The winners are chosen by a jury of renowned representatives from each sector, who conduct a comprehensive study of all projects in each area.

More information about Premis Ciutat de Barcelona 2014


About IRB Barcelona

The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).